... INDs in combat, and manu-facturing. Chapter Three examines the industrial model of drug The research described in this report was sponsored by the Office of the Secretary of Defense (OSD). The ... private-sector investment in bringing such products throughFDA licensing. Furthermore, the vaccine industry, as distinct from the pharmaceutical industry of which it is a part, is small and unsta-ble: ... achievement of its objectives. The department s personnelinvolved in the acquisition of CBW drugs must be competent by edu-cation, training, and experience in their understanding of FDA poli-cies...